Evidence map›Paper›PMID 29621205›Full record

ArticleMMWR. Morbidity and mortality weekly report2018

State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments - United States, 2015-2017.

Anne DiGiulio, Zach Jump, Annie Yu, Stephen Babb, Anna Schecter, Kisha-Ann S Williams, Debbie Yembra, Brian S Armour

Registry-linked trialAbstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04419922 (An Innovative Digital Smoking Cessation Intervention for Low-Income Adults With Substance Use Disorder), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04419922 unknown statusnot on this mapstarted 2020, after this paper: background citation

An Innovative Digital Smoking Cessation Intervention for Low-Income Adults With Substance Use Disorder

TypeobservationalSponsorBrightView LLCRan2020 to 2021Enrolled100ConditionsTobacco Use Disorder, Substance Use DisordersArmsSmartphone Contingency Management Intervention
3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anne DiGiulio
Zach Jump
Annie Yu
Stephen Babb
Anna Schecter
Kisha-Ann S Williams
Debbie Yembra
Brian S Armour

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cigarette smoking prevalence among Medicaid enrollees (25.3%) is approximately twice that of privately insured Americans (11.8%), placing Medicaid enrollees at increased risk for smoking-related disease and death (1). Medicaid spends approximately $39 billion annually on treating smoking-related diseases (2). Individual, group, and telephone counseling and seven Food and Drug Administration (FDA)-approved medications* are effective in helping tobacco users quit (3). Although state Medicaid coverage of tobacco cessation treatments improved during 2014-2015, coverage was still limited in most states (4). To monitor recent changes in state Medicaid cessation coverage for traditional (i.e., nonexpansion) Medicaid enrollees, the American Lung Association collected data on coverage of a total of nine cessation treatments: individual counseling, group counseling, and seven FDA-approved cessation medications

Indexed as

Health Services AccessibilitySmoking PreventionHumansInsurance CoverageMedicaidTobacco Use CessationUnited States

Identifiers

PMID29621205
PMCPMC5889244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.